What one share of Biomerica holds
Biomerica’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-08-31; the balance sheet is as of 2026-08-31.
| Sales | $1.41 |
|---|---|
| Profit | −$1.63 |
| Cash and investments | $0.59 |
| Book value | $0.79 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $6.84 | $0.64 | $0.19 | −$0.02 | — | $5.73 |
| 2013 | $6.95 | $0.58 | $0.28 | $1.22 | — | $6.42 |
| 2014 | $5.56 | −$0.23 | $0.15 | −$1.08 | — | $6.27 |
| 2015 | $5.26 | −$0.32 | $0.01 | −$0.44 | — | $5.92 |
| 2016 | $5.39 | −$1.57 | $0.10 | −$0.32 | — | $5.11 |
| 2017 | $5.56 | −$0.87 | $0.09 | −$0.79 | — | $4.22 |
| 2018 | $5.19 | −$1.37 | $0.12 | −$1.22 | — | $3.89 |
| 2019 | $4.52 | −$2.08 | $0.09 | −$2.04 | — | $3.29 |
| 2020 | $5.27 | −$2.11 | $0.03 | −$3.41 | — | $9.67 |
| 2021 | $4.83 | −$4.99 | $0.09 | −$3.61 | — | $6.00 |
| 2022 | $11.91 | −$2.86 | $0.04 | −$0.34 | — | $5.18 |
| 2023 | $3.02 | −$4.04 | $0.04 | −$3.13 | — | $5.58 |
| 2024 | $2.57 | −$2.84 | $0.02 | −$2.57 | — | $3.13 |
| 2025 | $2.31 | −$2.16 | — | — | — | $1.61 |
| 2026 | $1.53 | −$1.30 | — | — | — | $0.82 |
Common questions about Biomerica
How much does one share of Biomerica earn?
Over the last 12 months, Biomerica lost $1.63 for each share on $1.41 of sales.
Does Biomerica pay a dividend?
Biomerica didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Biomerica’s book value per share?
Biomerica’s book value is $0.79 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of August 31, 2026.
How much cash and debt does each share of Biomerica have?
Each share of Biomerica has $0.59 of cash and investments, as of August 31, 2026.
Has Biomerica bought back shares?
Biomerica’s share count rose about 228% from 2012 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.